Browsing by Title
Now showing items 2727-2746 of 2964
-
Travel‐related control measures to contain the COVID‐19 pandemic: a rapid review
(2020-09-16)BackgroundIn: In late 2019, first cases of coronavirus disease 2019, or COVID-19, caused by the novel coronavirus SARS-CoV-2, were reported inWuhan, China. Subsequently COVID-19 spread rapidly around the world. To contain ... -
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
(2020-03-27)Importance: Coronavirus disease 2019 (COVID-19) is a pandemic with no specific therapeutic agents and substantial mortality. It is critical to find new treatments. Objective: To determine whether convalescent plasma ... -
Treatment of patients with non-severe and severe COVID-19: an evidence-based guideline
(2020)On March 11, 2020, the World Health Organization (WHO) declared the COVID-19 viral disease a pandemic. The worldwide spread of coronavirus disease-2019 (COVID-19) represents a profound threat to human health. Patients with ... -
Treatment Response to Hydroxychloroquine, Lopinavir/Ritonavir, and Antibiotics for Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea
(2020-06-14)The authors have withdrawn this manuscript because of the controversy about hydroxychloroquine and potential changes in results after peer-review, the authors intend to share their results in formal publication. Therefore, ... -
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
(2020-07-01)Objective It has been hypothesised that the use of ACE inhibitors and angiotensin receptor blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The findings from the available observational ... -
Trends of SARS-CoV-2 infection worldwide: Role of population density, age structure, and climate on transmission and case fatality
(2020-05-22)Introduction The disease transmission pattern of COVID19 is highly heterogeneous, which suggests that the pandemic maybe driven by complex factors, which may include habitat suitability, region specific human mobility, and ... -
Triage de enfermería: pacientes con infección respiratoria aguda en establecimientos de salud: COVID-19
(2020-03-18)El «triage/clasificación» es un proceso que permite una gestión del riesgo clínico para poder establecer adecuadamente y con seguridad el flujo de pacientes cuando la demanda y las necesidades clínicas superan a los recursos. ... -
Triagem molecular para Zika vírus de unidades de sangue destinadas a transfusões intraútero e pacientes grávidas
(2016-06)A fonte original deste documento pode ser restrita, impedindo o acesso de leitores externos ao conteúdo, ou não estar mais disponível. Sendo assim, os usuários precisam utilizar outros recursos para recuperar essas informações. -
Triagem oftalmológica e avaliação de achados oculares em pacientes com suspeita de infecção pelo Zika vírus
(2016)A fonte original deste documento pode ser restrita, impedindo o acesso de leitores externos ao conteúdo, ou não estar mais disponível. Sendo assim, os usuários precisam utilizar outros recursos para recuperar essas informações. -
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
(2020-03-18)BACKGROUND: No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2. METHODS: We conducted a randomized, controlled, open-label trial involving hospitalized adult patients ... -
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
(2020-03-18)[Methods] We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection, which causes the respiratory illness Covid-19, and an oxygen saturation (Sao2 ) ... -
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
(2020-05-08)Background: Effective antiviral therapy is important for tackling the coronavirus disease 2019 (COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, lopinavir–ritonavir, and ribavirin for ... -
Troponina y mortalidad en pacientes con la COVID-19
(2020-04-03)Antecedentes: Dada la alta frecuencia de desenlaces adversos de la neumonía asociada a la COVID-19 se ha buscado identificar posibles variables asociadas (V.g. demográficas, clínicas, de imágenes diagnósticas y de laboratorio). ... -
Tutorial de navegação internações SUS sistema de notificação do Ministério da Saúde - e-SUS Notifica Versão 1.1.16, maio de 2020
(2020-05)Este tutorial foi desenvolvido pelo Departamento de Informática do SUS – DATASUS e será disponibilizado na página de suporte ao sistema de notificações no portal do DATASUS. O tutorial estará em constante evolução, para ... -
Twelve isolations of Zika virus from Aedes (Stegomyia) africanus
(1964)In continuation of a series of studies of arboreal mosquitos as virus vectors in Uganda, 12 strains of Zika virus and one strain of another Group B arbovirus were isolated between November 1961 and June 1963 from pools of ... -
Twenty-four cases of imported zika virus infections diagnosed by molecular methods
(2016)Zika virus is an emerging flavivirus widely spreading through Latin America. Molecular diagnosis of the infection can be performed using serum, urine and saliva samples, although a well-defined diagnostic algorithm is not ... -
Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014
(2014)We report two cases of Zika fever in Japan, which were imported from French Polynesia, where on 6 November 2013 public health authorities reported an outbreak of subfebrile illness with rash due to Zika virus (ZIKV). The ... -
Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014
(2014)We present two cases of imported Zika fever to Japan, in travellers returning from French Polynesia, where an outbreak due to Zika virus (ZIKV) is ongoing since week 41 of 2013. This report serves to raise awareness among ... -
Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection
(2016-06)During mammalian pregnancy, the placenta acts as a barrier between the maternal and fetal compartments. The recently observed association between Zika virus (ZIKV) infection during human pregnancy and fetal microcephaly ...